Asset Management One Co. Ltd. Increases Holdings in Encompass Health Corporation $EHC

Asset Management One Co. Ltd. grew its holdings in shares of Encompass Health Corporation (NYSE:EHC) by 691.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 56,773 shares of the company’s stock after buying an additional 49,604 shares during the quarter. Asset Management One Co. Ltd. owned 0.06% of Encompass Health worth $6,961,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. OneDigital Investment Advisors LLC purchased a new stake in shares of Encompass Health during the 1st quarter valued at about $263,000. GAMMA Investing LLC raised its position in shares of Encompass Health by 21.5% during the 1st quarter. GAMMA Investing LLC now owns 2,366 shares of the company’s stock valued at $240,000 after buying an additional 419 shares in the last quarter. Sequoia Financial Advisors LLC raised its position in shares of Encompass Health by 6.7% during the 1st quarter. Sequoia Financial Advisors LLC now owns 2,727 shares of the company’s stock valued at $276,000 after buying an additional 172 shares in the last quarter. Cambridge Investment Research Advisors Inc. raised its position in shares of Encompass Health by 30.1% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 9,597 shares of the company’s stock valued at $972,000 after buying an additional 2,218 shares in the last quarter. Finally, Intech Investment Management LLC raised its position in shares of Encompass Health by 21.8% during the 1st quarter. Intech Investment Management LLC now owns 21,329 shares of the company’s stock valued at $2,160,000 after buying an additional 3,815 shares in the last quarter. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Encompass Health Price Performance

Shares of EHC stock opened at $126.40 on Wednesday. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06. The company has a market capitalization of $12.73 billion, a P/E ratio of 24.74, a P/E/G ratio of 2.22 and a beta of 0.93. The company’s 50-day simple moving average is $124.46 and its two-hundred day simple moving average is $118.64. Encompass Health Corporation has a one year low of $87.85 and a one year high of $127.99.

Encompass Health (NYSE:EHC) last issued its earnings results on Wednesday, March 16th. The company reported $0.93 EPS for the quarter. The business had revenue of $136.30 million for the quarter. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. As a group, equities analysts anticipate that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be paid a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Friday, January 2nd. Encompass Health’s dividend payout ratio is currently 14.87%.

Analyst Ratings Changes

A number of research firms recently weighed in on EHC. Weiss Ratings reissued a “buy (b+)” rating on shares of Encompass Health in a research report on Wednesday, October 8th. Truist Financial increased their price objective on shares of Encompass Health from $135.00 to $140.00 and gave the stock a “buy” rating in a research report on Thursday, August 14th. Zacks Research raised shares of Encompass Health from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, October 21st. UBS Group increased their price objective on shares of Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a research report on Thursday, October 2nd. Finally, KeyCorp increased their price objective on shares of Encompass Health from $135.00 to $140.00 and gave the stock an “overweight” rating in a research report on Tuesday, September 16th. Two equities research analysts have rated the stock with a Strong Buy rating and eight have given a Buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Buy” and an average target price of $139.86.

Insider Buying and Selling

In other Encompass Health news, EVP Patrick William Tuer sold 1,020 shares of the company’s stock in a transaction dated Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total value of $126,061.80. Following the transaction, the executive vice president directly owned 18,846 shares in the company, valued at $2,329,177.14. This represents a 5.13% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 2.10% of the stock is owned by corporate insiders.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.